Guidant Multi-Link Pixel
This article was originally published in The Gray Sheet
Executive Summary
First human implant of the coronary stent system for small vessels is performed July 11 at Sacred Heart Medical Center in Eugene, Oregon. The stent is intended to treat threatened abrupt closures of first-time or recurring blockages in small vessels with diameters of less than 3.0 mm. Separately, the firm has launched a multi-center safety and feasibility study to evaluate the AccuNet embolic protection system to reduce stroke during minimally invasive carotid artery stenting procedures. Guidant had submitted an IDE for the 50-patient study in May (1"The Gray Sheet" May 29, p. 3)
You may also be interested in...
HCFA Conditional Coverage For Clinical Trials Unlikely In Near-Term
The Health Care Financing Administration will not provide "conditional coverage" under Medicare for the ongoing REMATCH trial evaluating congestive heart failure treatment using Thermo Cardiosystems, Inc.'s HeartMate left ventricular assist device.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.